Orgenesis Inc . (NASDAQ:ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) in order to improve access and outcomes in healthcare, today announced a strategic partnership agreement with Harley Street Healthcare Group (HSHG) – an innovative and forward-looking healthcare provider focused on delivering world-class, proactive, personalized and preventative health & wellness services, based in London with a global presence. This partnership aims to accelerate the clinical development and commercialization of advanced wellness and longevity therapies and products to a global customer base, aimed at significantly reducing the impact of lifestyle-related illnesses on people’s health.
Under the terms of the agreement, Orgenesis and HSHG will establish a joint venture (JV), with Orgenesis owning 49% and HSHG owning 51% of the entity. The JV will focus on launching innovative health and wellness services, including personalized preventative care and regenerative therapies. The goal is to establish a comprehensive "Health-Wellness-as-a-Service" (HWAAS) model, leveraging HSHG’s established healthcare network and Orgenesis' cutting-edge biotech innovations.
The JV intends to introduce a suite of wellness and longevity products by the end of 2024 that will include immune cell banking, aging and longevity therapies, preventative illness screening, and regenerative therapies using stem cells. The initial rollout will target key global regions, including the United Kingdom, UAE, MENA, Canada, ASEAN, the Balkans, Africa, Latam, and the Indian subcontinent.
In connection with the agreement, HSHG has agreed to invest up to $10 million over three years into Orgenesis and the joint venture.
Vered Caplan, CEO of Orgenesis, commented, “This partnership with Harley Street Healthcare Group marks a significant milestone in Orgenesis’ strategy to expand our footprint in the global wellness market. By combining our expertise in cell and gene therapies with HSHG’s clinical excellence, we are poised to deliver innovative health solutions and our goal will be to redefine patient care and longevity. Importantly, Harley Street has demonstrated its commitment to the JV through a direct investment in both Orgenesis and the JV. We could not be more excited about this collaboration and its potential to rapidly deploy cutting-edge, longevity-focused health and wellness services.”
Sanjeev Kumar, Founder & Chief Visionary Officer of Harley Street Healthcare Group, added, “In our mission to making 90 the new 50 a reality, we are thrilled to collaborate with Orgenesis and have Vered and her team be our strategic partners in this transformative venture. I believe that our shared vision of enhancing health outcomes through innovative therapies and services will pave the way for a new era in personalized medicine and preventative care.”
About Harley Street Healthcare Group
Harley Street Healthcare Group (HSHG), including its brands and subsidiaries, the Harley Club and HARLEY of LONDON, provides integrated health & wellness services to its global client base by bringing together the best of modern medicine, state-of-the-art technological innovations wrapped around the resourcefulness of ancient healing systems. Based in London with a growing global presence, HSHG is focused on being an invested partner in the health & wellness journey of its customers through a proactive, personalized and preventative approach to delivering healthcare, moving away from the current industrial sick care system.
More information on the group is available at:
www.theharleyclub.com, www.harleyoflondon.co.uk